These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 11934305)
21. Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. Fernandes AM; Fernandes TG; Diogo MM; da Silva CL; Henrique D; Cabral JM J Biotechnol; 2007 Oct; 132(2):227-36. PubMed ID: 17644203 [TBL] [Abstract][Full Text] [Related]
22. Bioreactor expansion of human neural precursor cells in serum-free media retains neurogenic potential. Baghbaderani BA; Mukhida K; Sen A; Kallos MS; Hong M; Mendez I; Behie LA Biotechnol Bioeng; 2010 Mar; 105(4):823-33. PubMed ID: 19882735 [TBL] [Abstract][Full Text] [Related]
23. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288 [TBL] [Abstract][Full Text] [Related]
24. Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Côme J; Nissan X; Aubry L; Tournois J; Girard M; Perrier AL; Peschanski M; Cailleret M Tissue Eng Part C Methods; 2008 Dec; 14(4):289-98. PubMed ID: 18710335 [TBL] [Abstract][Full Text] [Related]
25. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184 [TBL] [Abstract][Full Text] [Related]
26. Expansion of mammalian neural stem cells in bioreactors: effect of power input and medium viscosity. Sen A; Kallos MS; Behie LA Brain Res Dev Brain Res; 2002 Mar; 134(1-2):103-13. PubMed ID: 11947941 [TBL] [Abstract][Full Text] [Related]
33. The stem cells as a potential treatment for neurodegeneration. Daniela F; Vescovi AL; Bottai D Methods Mol Biol; 2007; 399():199-213. PubMed ID: 18309934 [TBL] [Abstract][Full Text] [Related]
34. Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. Kallos MS; Behie LA Biotechnol Bioeng; 1999 May; 63(4):473-83. PubMed ID: 10099628 [TBL] [Abstract][Full Text] [Related]
35. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production. Lee YY; Yap MG; Hu WS; Wong KT Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594 [TBL] [Abstract][Full Text] [Related]
36. Increased rate of chondrocyte aggregation in a wavy-walled bioreactor. Bueno EM; Bilgen B; Carrier RL; Barabino GA Biotechnol Bioeng; 2004 Dec; 88(6):767-77. PubMed ID: 15515164 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Forraz N; Pettengell R; McGuckin CP Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396 [TBL] [Abstract][Full Text] [Related]